Skip to main content

Table 1 Clinical characteristics of 13 pregnant women

From: Deleterious genetic variants in ciliopathy genes increase risk of ritodrine-induced cardiac and pulmonary side effects

Sample

Maternal age (years)

Gestational age at administration (weeks)

Side effect(s)

S1

30–39

31.4

Dyspnea

S2

30–39

30.2

Pulmonary edema, Pulmonary congestion

S3

30–39

34.0

Tachycardia, Dyspnea

S4

30–39

35.1

Dyspnea

S5

20–29

35.4

Pulmonary edema, Dyspnea

S6

30–39

36.5

Tachycardia, Dyspnea

S7

30–39

15.2

Tachycardia, Dyspnea

S8

20–29

33.5

Dyspnea

S9

40–49

27.6

Tachycardia, Dyspnea, Palpitation

S10

20–29

20.3

Tachycardia, Dyspnea, Headache, Sweating

S11

20–29

30.6

Dyspnea, Palpitation

S12

20–29

30.5

Pulmonary edema

S13

40–49

32.2

Pulmonary edema